+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Vitamin D Therapy Market Research Report by Route of Administration, Purchasing Pattern, Age Group, Indication, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 253 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 4829954
UP TO OFF until Dec 31st 2022
The Global Vitamin D Therapy Market size was estimated at USD 2,530.95 million in 2021, USD 2,846.63 million in 2022, and is projected to grow at a CAGR 12.64% to reach USD 5,172.14 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Vitamin D Therapy to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Route of Administration, the market was studied across Oral Route of Administration and Parenteral Route of Administration.
  • Based on Purchasing Pattern, the market was studied across Over-The-Counter Drugs and Prescription Drugs.
  • Based on Age Group, the market was studied across Adults, Children, and Senior Adults.
  • Based on Indication, the market was studied across Autoimmune Disorders, Muscle Weakness, Osteoporosis, Rickets, and Skin Diseases.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Vitamin D Therapy market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Vitamin D Therapy Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Vitamin D Therapy Market, including Abbott Laboratories, Alkem Laboratories Ltd., Amway Corporation, Cadila Healthcare Ltd., Cipla Inc., Glanbia PLC, GlaxoSmithKline PLC, Mankind Pharma Ltd, Merck & Co., Inc., Novartis AG, Otsuka Holdings Co. Ltd, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., and Torrent Pharmaceuticals Ltd..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Vitamin D Therapy Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Vitamin D Therapy Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Vitamin D Therapy Market?
4. What is the competitive strategic window for opportunities in the Global Vitamin D Therapy Market?
5. What are the technology trends and regulatory frameworks in the Global Vitamin D Therapy Market?
6. What is the market share of the leading vendors in the Global Vitamin D Therapy Market?
7. What modes and strategic moves are considered suitable for entering the Global Vitamin D Therapy Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Consumer Awareness About Vitamin D Deficiency
5.1.1.2. Presence of a Large Target Patient Population
5.1.2. Restraints
5.1.2.1. Limited Clinical Trials
5.1.3. Opportunities
5.1.3.1. Increasing Growth Opportunities in Countries with a High Prevalence of Undernutrition
5.1.4. Challenges
5.1.4.1. Availability of Fortified Foods
5.2. Cumulative Impact of COVID-19
6. Vitamin D Therapy Market, by Route of Administration
6.1. Introduction
6.2. Oral Route of Administration
6.3. Parenteral Route of Administration
7. Vitamin D Therapy Market, by Purchasing Pattern
7.1. Introduction
7.2. Over-The-Counter Drugs
7.3. Prescription Drugs
8. Vitamin D Therapy Market, by Age Group
8.1. Introduction
8.2. Adults
8.3. Children
8.4. Senior Adults
9. Vitamin D Therapy Market, by Indication
9.1. Introduction
9.2. Autoimmune Disorders
9.3. Muscle Weakness
9.4. Osteoporosis
9.5. Rickets
9.6. Skin Diseases
10. Americas Vitamin D Therapy Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Vitamin D Therapy Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
12. Europe, Middle East & Africa Vitamin D Therapy Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. Fpnv Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, by Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Abbott Laboratories
14.2. Alkem Laboratories Ltd.
14.3. Amway Corporation
14.4. Cadila Healthcare Ltd.
14.5. Cipla Inc.
14.6. Glanbia plc
14.7. GlaxoSmithKline plc
14.8. Mankind Pharma Ltd
14.9. Merck & Co., Inc.
14.10. Novartis Ag
14.11. Otsuka Holdings Co. Ltd
14.12. Pfizer Inc.
14.13. Sanofi
14.14. Sun Pharmaceutical Industries Ltd.
14.15. Torrent Pharmaceuticals Ltd.
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL VITAMIN D THERAPY MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL VITAMIN D THERAPY MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. GLOBAL VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VITAMIN D THERAPY MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL VITAMIN D THERAPY MARKET DYNAMICS
FIGURE 8. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2021 VS 2027 (%)
FIGURE 9. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2027
FIGURE 11. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY ORAL ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY ORAL ROUTE OF ADMINISTRATION, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY PARENTERAL ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY PARENTERAL ROUTE OF ADMINISTRATION, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2021 VS 2027 (%)
FIGURE 16. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2021 VS 2027 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2027
FIGURE 18. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2019-2027 (USD MILLION)
FIGURE 19. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY PRESCRIPTION DRUGS, 2019-2027 (USD MILLION)
FIGURE 21. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 22. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2021 VS 2027 (%)
FIGURE 23. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2021 VS 2027 (USD MILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2027
FIGURE 25. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY ADULTS, 2019-2027 (USD MILLION)
FIGURE 26. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY ADULTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 27. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY CHILDREN, 2019-2027 (USD MILLION)
FIGURE 28. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY CHILDREN, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 29. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY SENIOR ADULTS, 2019-2027 (USD MILLION)
FIGURE 30. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY SENIOR ADULTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 31. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2021 VS 2027 (%)
FIGURE 32. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2021 VS 2027 (USD MILLION)
FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2027
FIGURE 34. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2019-2027 (USD MILLION)
FIGURE 35. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 36. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY MUSCLE WEAKNESS, 2019-2027 (USD MILLION)
FIGURE 37. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY MUSCLE WEAKNESS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 38. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY OSTEOPOROSIS, 2019-2027 (USD MILLION)
FIGURE 39. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY OSTEOPOROSIS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 40. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY RICKETS, 2019-2027 (USD MILLION)
FIGURE 41. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY RICKETS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 42. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY SKIN DISEASES, 2019-2027 (USD MILLION)
FIGURE 43. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY SKIN DISEASES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 44. AMERICAS VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 46. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 47. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2027
FIGURE 48. ARGENTINA VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. BRAZIL VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. CANADA VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. MEXICO VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. UNITED STATES VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 54. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 55. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY STATE, 2027
FIGURE 56. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 58. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 59. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2027
FIGURE 60. AUSTRALIA VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. CHINA VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. INDIA VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. INDONESIA VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. JAPAN VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. MALAYSIA VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. PHILIPPINES VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. SINGAPORE VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. SOUTH KOREA VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. TAIWAN VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 70. THAILAND VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 72. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 73. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 74. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2027
FIGURE 75. FRANCE VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 76. GERMANY VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 77. ITALY VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 78. NETHERLANDS VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 79. QATAR VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 80. RUSSIA VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 81. SAUDI ARABIA VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 82. SOUTH AFRICA VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 83. SPAIN VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 84. UNITED ARAB EMIRATES VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 85. UNITED KINGDOM VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 86. GLOBAL VITAMIN D THERAPY MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 87. GLOBAL VITAMIN D THERAPY MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 88. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL VITAMIN D THERAPY MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL VITAMIN D THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 6. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY ORAL ROUTE OF ADMINISTRATION, BY REGION, 2019-2027 (USD MILLION)
TABLE 7. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY ORAL ROUTE OF ADMINISTRATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY ORAL ROUTE OF ADMINISTRATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY ORAL ROUTE OF ADMINISTRATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY ORAL ROUTE OF ADMINISTRATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY PARENTERAL ROUTE OF ADMINISTRATION, BY REGION, 2019-2027 (USD MILLION)
TABLE 12. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY PARENTERAL ROUTE OF ADMINISTRATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY PARENTERAL ROUTE OF ADMINISTRATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY PARENTERAL ROUTE OF ADMINISTRATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY PARENTERAL ROUTE OF ADMINISTRATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2019-2027 (USD MILLION)
TABLE 17. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY REGION, 2019-2027 (USD MILLION)
TABLE 18. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY STATE, 2019-2027 (USD MILLION)
TABLE 20. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 22. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2019-2027 (USD MILLION)
TABLE 23. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY PRESCRIPTION DRUGS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY PRESCRIPTION DRUGS, BY STATE, 2019-2027 (USD MILLION)
TABLE 25. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY PRESCRIPTION DRUGS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY PRESCRIPTION DRUGS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 27. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 28. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY ADULTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 29. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY ADULTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY ADULTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 31. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY ADULTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 32. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY ADULTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 33. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY CHILDREN, BY REGION, 2019-2027 (USD MILLION)
TABLE 34. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY CHILDREN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY CHILDREN, BY STATE, 2019-2027 (USD MILLION)
TABLE 36. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY CHILDREN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 37. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY CHILDREN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 38. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY SENIOR ADULTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 39. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY SENIOR ADULTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY SENIOR ADULTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 41. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY SENIOR ADULTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 42. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY SENIOR ADULTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 43. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 44. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 45. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 46. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 47. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 48. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 49. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY MUSCLE WEAKNESS, BY REGION, 2019-2027 (USD MILLION)
TABLE 50. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY MUSCLE WEAKNESS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 51. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY MUSCLE WEAKNESS, BY STATE, 2019-2027 (USD MILLION)
TABLE 52. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY MUSCLE WEAKNESS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 53. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY MUSCLE WEAKNESS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 54. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY OSTEOPOROSIS, BY REGION, 2019-2027 (USD MILLION)
TABLE 55. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY OSTEOPOROSIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 56. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY OSTEOPOROSIS, BY STATE, 2019-2027 (USD MILLION)
TABLE 57. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY OSTEOPOROSIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY OSTEOPOROSIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 59. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY RICKETS, BY REGION, 2019-2027 (USD MILLION)
TABLE 60. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY RICKETS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 61. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY RICKETS, BY STATE, 2019-2027 (USD MILLION)
TABLE 62. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY RICKETS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 63. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY RICKETS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 64. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY SKIN DISEASES, BY REGION, 2019-2027 (USD MILLION)
TABLE 65. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY SKIN DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 66. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY SKIN DISEASES, BY STATE, 2019-2027 (USD MILLION)
TABLE 67. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY SKIN DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY SKIN DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 69. AMERICAS VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 70. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 71. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 72. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2019-2027 (USD MILLION)
TABLE 73. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 74. AMERICAS VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 75. ARGENTINA VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 76. ARGENTINA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 77. ARGENTINA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2019-2027 (USD MILLION)
TABLE 78. ARGENTINA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 79. ARGENTINA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 80. BRAZIL VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 81. BRAZIL VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 82. BRAZIL VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2019-2027 (USD MILLION)
TABLE 83. BRAZIL VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 84. BRAZIL VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 85. CANADA VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 86. CANADA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 87. CANADA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2019-2027 (USD MILLION)
TABLE 88. CANADA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 89. CANADA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 90. MEXICO VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 91. MEXICO VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 92. MEXICO VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2019-2027 (USD MILLION)
TABLE 93. MEXICO VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 94. MEXICO VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 95. UNITED STATES VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 96. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 97. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 98. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2019-2027 (USD MILLION)
TABLE 99. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 100. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 101. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 102. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 103. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 104. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2019-2027 (USD MILLION)
TABLE 105. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 106. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 107. AUSTRALIA VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 108. AUSTRALIA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 109. AUSTRALIA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2019-2027 (USD MILLION)
TABLE 110. AUSTRALIA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 111. AUSTRALIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 112. CHINA VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 113. CHINA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 114. CHINA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2019-2027 (USD MILLION)
TABLE 115. CHINA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 116. CHINA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 117. INDIA VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 118. INDIA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 119. INDIA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2019-2027 (USD MILLION)
TABLE 120. INDIA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 121. INDIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 122. INDONESIA VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 123. INDONESIA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 124. INDONESIA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2019-2027 (USD MILLION)
TABLE 125. INDONESIA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 126. INDONESIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 127. JAPAN VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 128. JAPAN VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 129. JAPAN VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2019-2027 (USD MILLION)
TABLE 130. JAPAN VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 131. JAPAN VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 132. MALAYSIA VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 133. MALAYSIA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 134. MALAYSIA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2019-2027 (USD MILLION)
TABLE 135. MALAYSIA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 136. MALAYSIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 137. PHILIPPINES VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 138. PHILIPPINES VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 139. PHILIPPINES VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2019-2027 (USD MILLION)
TABLE 140. PHILIPPINES VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 141. PHILIPPINES VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 142. SINGAPORE VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 143. SINGAPORE VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 144. SINGAPORE VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2019-2027 (USD MILLION)
TABLE 145. SINGAPORE VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 146. SINGAPORE VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 147. SOUTH KOREA VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 148. SOUTH KOREA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 149. SOUTH KOREA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2019-2027 (USD MILLION)
TABLE 150. SOUTH KOREA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 151. SOUTH KOREA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 152. TAIWAN VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 153. TAIWAN VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 154. TAIWAN VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2019-2027 (USD MILLION)
TABLE 155. TAIWAN VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 156. TAIWAN VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 157. THAILAND VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 158. THAILAND VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 159. THAILAND VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2019-2027 (USD MILLION)
TABLE 160. THAILAND VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 161. THAILAND VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2019-2027 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 168. FRANCE VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 169. FRANCE VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 170. FRANCE VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2019-2027 (USD MILLION)
TABLE 171. FRANCE VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 172. FRANCE VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 173. GERMANY VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 174. GERMANY VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 175. GERMANY VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2019-2027 (USD MILLION)
TABLE 176. GERMANY VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 177. GERMANY VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 178. ITALY VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 179. ITALY VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 180. ITALY VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2019-2027 (USD MILLION)
TABLE 181. ITALY VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 182. ITALY VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 183. NETHERLANDS VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 184. NETHERLANDS VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 185. NETHERLANDS VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2019-2027 (USD MILLION)
TABLE 186. NETHERLANDS VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 187. NETHERLANDS VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 188. QATAR VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 189. QATAR VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 190. QATAR VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2019-2027 (USD MILLION)
TABLE 191. QATAR VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 192. QATAR VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 193. RUSSIA VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 194. RUSSIA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 195. RUSSIA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2019-2027 (USD MILLION)
TABLE 196. RUSSIA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 197. RUSSIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 198. SAUDI ARABIA VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 199. SAUDI ARABIA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 200. SAUDI ARABIA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2019-2027 (USD MILLION)
TABLE 201. SAUDI ARABIA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 202. SAUDI ARABIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 203. SOUTH AFRICA VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 204. SOUTH AFRICA VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 205. SOUTH AFRICA VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2019-2027 (USD MILLION)
TABLE 206. SOUTH AFRICA VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 207. SOUTH AFRICA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 208. SPAIN VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 209. SPAIN VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 210. SPAIN VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2019-2027 (USD MILLION)
TABLE 211. SPAIN VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 212. SPAIN VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2019-2027 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 218. UNITED KINGDOM VITAMIN D THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 219. UNITED KINGDOM VITAMIN D THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 220. UNITED KINGDOM VITAMIN D THERAPY MARKET SIZE, BY PURCHASING PATTERN, 2019-2027 (USD MILLION)
TABLE 221. UNITED KINGDOM VITAMIN D THERAPY MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 222. UNITED KINGDOM VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 223. GLOBAL VITAMIN D THERAPY MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 224. GLOBAL VITAMIN D THERAPY MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 225. GLOBAL VITAMIN D THERAPY MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 226. GLOBAL VITAMIN D THERAPY MARKET RANKING
TABLE 227. GLOBAL VITAMIN D THERAPY MARKET SHARE, BY KEY PLAYER, 2021
TABLE 228. GLOBAL VITAMIN D THERAPY MARKET MERGER & ACQUISITION
TABLE 229. GLOBAL VITAMIN D THERAPY MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 230. GLOBAL VITAMIN D THERAPY MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 231. GLOBAL VITAMIN D THERAPY MARKET INVESTMENT & FUNDING
TABLE 232. GLOBAL VITAMIN D THERAPY MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 233. GLOBAL VITAMIN D THERAPY MARKET: LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • Alkem Laboratories Ltd.
  • Amway Corporation
  • Cadila Healthcare Ltd.
  • Cipla Inc.
  • Glanbia PLC
  • GlaxoSmithKline PLC
  • Mankind Pharma Ltd
  • Merck & Co., Inc.
  • Novartis AG
  • Otsuka Holdings Co. Ltd
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Ltd.

Methodology

Loading
LOADING...